Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 467 Records) |
Query Trace: PCSK9[original query] |
---|
Low-Cost High-Throughput Genotyping for Diagnosing Familial Hypercholesterolemia. Circulation. Genomic and precision medicine 2023 9 e004103. Shirin Ibrahim, Jeroen van Rooij, Annemieke J M H Verkerk, Jard de Vries, Linda Zuurbier, Joep Defesche, Jorge Peter, Willemijn A M Schonck, Bahar Sedaghati-Khayat, G Kees Hovingh, André G Uitterlinden, Erik S G Stroes, Laurens F Reeska |
LDLR and PCSK9 3´UTR variants and their putative effects on microRNA molecular interactions in familial hypercholesterolemia: a computational approach. Molecular biology reports 2023 9 . Renata Caroline Costa de Freitas, Raul Hernandes Bortolin, Jessica Bassani Borges, Victor Fernandes de Oliveira, Carolina Dagli-Hernandez, Elisangela da Silva Rodrigues Marçal, Gisele Medeiros Bastos, Rodrigo Marques Gonçalves, Andre Arpad Faludi, Vivian Nogueira Silbiger, André Ducati Luchessi, Rosario Dominguez Crespo Hirata, Mario Hiroyuki Hira |
Assessing the impact of PCSK9 and HMGCR inhibition on liver function: drug-target Mendelian Randomization analyses in 4 ancestries. Cellular and molecular gastroenterology and hepatology 2023 9 . Daniel B Rosoff, Andrew S Bell, Josephin Wagner, Lucas A Mavromatis, Ali Hamandi, Lauren Park, Jeesun Jung, Falk W Loho |
Amplified Risk of Intracranial Artery Stenosis/Occlusion Associated With RNF213 p.R4810K in Familial Hypercholesterolemia. JACC. Asia 2023 8 3 (4): 625-633. Kotaro Noda, Yorito Hattori, Mika Hori, Yuriko Nakaoku, Akito Tanaka, Takeshi Yoshimoto, Kunihiro Nishimura, Takanori Yokota, Mariko Harada-Shiba, Masafumi Iha |
Genetic testing for familial hypercholesterolemia in Quebec, Canada: a single-centre retrospective cohort study. CMAJ open 2023 8 11 (4): E754-E764. Amanda Guerin, Iulia Iatan, Isabelle Ruel, Linda Fri Ngufor, Jacques Gene |
Causal relationship between PCSK9 inhibitor and autoimmune diseases: a drug target Mendelian randomization study. Arthritis research & therapy 2023 8 25 (1): 148. Weijia Xie, Jiaxin Li, Hao Du, Jian X |
Genetic Characteristics of Latvian Patients with Familial Hypercholesterolemia: The First Analysis from Genome-Wide Sequencing. Journal of clinical medicine 2023 8 12 (15): . Gustavs Latkovskis, Raimonds Rescenko-Krums, Georgijs Nesterovics, Monta Briviba, Vita Saripo, Dainus Gilis, Elizabete Terauda, Ruta Meiere, Gunda Skudrina, Andrejs Erglis, Joana Rita Chora, Mafalda Bourbon, Janis Klovi |
Correlations of PCSK9 and LDLR gene polymorphisms as well as serum PCSK9 levels with atherosclerosis and lipid metabolism in maintenance hemodialysis patients. Journal of clinical pharmacology 2023 8 . Jun Cui, Yuxiang Qiu, Ningsu Kang, Jianxun Lu, Lu Zhe |
Association between the use of lipid-lowering drugs and the risk of inflammatory bowel disease. European journal of clinical investigation 2023 7 e14067. Xuxu Liu, Zhenyi Lv, Zhihong Xie, Qiang Wang, Wenchao Yao, Jingjing Yu, Qingxu Jing, Xianzhi Meng, Biao Ma, Dongbo Xue, Chenjun H |
In Autism Etiology: Sequence Variations, Protein Concentration, and Promoter Methylation. Archives of medical research 2023 7 54 (6): 102860. Sohair Salem, Rehab Mosaad, Randa Lotfy, Engy Ashaat, Samira Isma |
Human gain-of-function variants in HNF1A confer protection from diabetes but independently increase hepatic secretion of atherogenic lipoproteins. Cell genomics 2023 7 3 (7): 100339. Natalie DeForest, Babu Kavitha, Siqi Hu, Roi Isaac, Lynne Krohn, Minxian Wang, Xiaomi Du, Camila De Arruda Saldanha, Jenny Gylys, Edoardo Merli, Ruben Abagyan, Laeya Najmi, Viswanathan Mohan, , , Jason Flannick, Gina M Peloso, Philip L S M Gordts, Sven Heinz, Aimee M Deaton, Amit V Khera, Jerrold Olefsky, Venkatesan Radha, Amit R Majith |
Advanced progress of the relationship between PCSK9 monoclonal antibodies and hyperglycemic adverse events. Frontiers in cardiovascular medicine 2023 7 10 1117143. Ruixing Zhang, Yongxiang Wang, Yu Peng, Jing Zhao, Zheng Zha |
Detrimental effects of PCSK9 loss-of-function in the pediatric host response to sepsis are mediated through independent influence on Angiopoietin-1. Critical care (London, England) 2023 6 27 (1): 250. Mihir R Atreya, Natalie Z Cvijanovich, Julie C Fitzgerald, Scott L Weiss, Michael T Bigham, Parag N Jain, Adam J Schwarz, Riad Lutfi, Jeffrey Nowak, Geoffrey L Allen, Neal J Thomas, Jocelyn R Grunwell, Torrey Baines, Michael Quasney, Bereketeab Haileselassie, Matthew N Alder, Patrick Lahni, Scarlett Ripberger, Adesuwa Ekunwe, Kyle R Campbell, Keith R Walley, Stephen W Standa |
Is It Ever Wise to Edit Wild-Type Alleles? Engineered CRISPR Alleles Versus Millions of Years of Human Evolution. Arteriosclerosis, thrombosis, and vascular biology 2023 12 . Darby W Kozan, Steven A Farb |
Bidirectional causal relationship between hypercholesterolemia and ischemic heart disease: a Mendelian randomization study. Frontiers in cardiovascular medicine 2023 12 10 1302282. Ying Jiang, Wenpeng Yu, Jianliang Zhou, Xiao Do |
Causal role of lipid metabolism in pulmonary alveolar proteinosis: an observational and mendelian randomisation study. Thorax 2023 12 . Junfeng Huang, Zikai Lin, Jinsheng Lin, Shuojia Xie, Shixin Xia, Gengjia Chen, Ziwen Zheng, Zhe Xu, Fangcheng Liu, Hongkai Wu, Shiyue |
Unravelling the genetic background of individuals with a clinical Familial Hypercholesterolemia phenotype. Journal of lipid research 2023 12 100490. Ana Margarida Medeiros, Ana Catarina Alves, Beatriz Miranda, Joana Rita Chora, Mafalda Bourbon, |
Causal effects of circulating lipids and lipid-lowering drugs on the risk of urinary stones: a Mendelian randomization study. Frontiers in endocrinology 2023 12 14 1301163. Zilong Tan, Jing Hong, Aochuan Sun, Mengdi Ding, Jianwu Sh |
Lipid-lowering drugs affect lung cancer risk via sphingolipid metabolism: a drug-target Mendelian randomization study. Frontiers in genetics 2023 11 14 1269291. Honglin Li, Lei Zhang, Feiran Yang, Xiaoteng Feng, Rong Fu, Ruohan Zhao, Xiurong Li, Huijie |
E670G PCSK9 polymorphism in HeFH & CAD with diabetes: is the bridge to personalized therapy within reach? Frontiers in clinical diabetes and healthcare 2023 11 4 1277288. Rano Alieva, Aleksandr Shek, Alisher Abdullaev, Khurshid Fozilov, Shovkat Khoshimov, Guzal Abdullaeva, Dariya Zakirova, Rano Kurbanova, Lilia Kan, Andrey K |
Causal association between lipid-lowering drugs and female reproductive endocrine diseases: a drug-targeted Mendelian randomization study. Frontiers in endocrinology 2023 11 14 1295412. Jing Zhao, Runfang Wang, Liyun Song, Hua Han, Pei Wang, Yuan Zhao, Yunxia Zhang, Hongzhen Zha |
Searching for new genes associated with the familial hypercholesterolemia phenotype using whole-genome sequencing and machine learning. Vavilovskii zhurnal genetiki i selektsii 2023 10 27 (5): 522-529. D E Ivanoshchuk, A B Kolker, O V Timoshchenko, S E Semaev, E V Shakhtshneid |
Genetic backgrounds and diagnosis of familial hypercholesterolemia. Clinical genetics 2023 10 . Joanna Rogozik, Renata G?ówczy?ska, Marcin Grabows |
Exploring PCSK9 Genetic Impact on Lipoprotein(a) via Dual Approaches: Association and Mendelian Randomization. International journal of molecular sciences 2023 10 24 (19): . Ya-Ching Chang, Lung-An Hsu, Yu-Lin |
Association between genetically proxied PCSK9 inhibition and systemic lupus erythematosus risk: A mendelian randomization study. International journal of rheumatic diseases 2024 4 27 (4): e15106. Xincan Ji, Hao-Yang Guo, Mengqi Han, Hui Peng, Hui Yu |
Blood lipids, lipid-regulatory medications, and risk of bladder cancer: a Mendelian randomization study. Frontiers in nutrition 2024 1 10 992608. Zhang Cheng, Fangdie Ye, Yingchun Liang, Chenyang Xu, Zheyu Zhang, Yuxi Ou, Xinan Chen, Xiyu Dai, Zezhong Mou, Weijian Li, Yiling Chen, Quan Zhou, Lujia Zou, Shanhua Mao, Haowen Jia |
Mendelian randomization study of lipid metabolism characteristics and migraine risk. European journal of pain (London, England) 2024 1 . Peiwei Hong, Lin Han, Yang W |
Genetically proxied low-density lipoprotein cholesterol lowering via PCSK9-inhibitor drug targets and risk of congenital malformations. European journal of preventive cardiology 2024 1 . Maddalena Ardissino, Eric A W Slob, Rohin K Reddy, Alec P Morley, Art Schuermans, Phoebe Hill, Catherine Williamson, Michael C Honigberg, Antonio de Marvao, Fu Siong |
Polymorphisms rs562556 and rs2479409 of the PCSK9 gene associated with obesity and cardiovascular disease. Central European journal of public health 2024 1 31 (Suppl 1): S82-S88. Hedviga Vašková, Janka Porá?ová, Miriama Šlebodová, So?a Kalafutová, Mária Kone?ná, Vincent Sedlák, Tatiana Kimáková, Marta Mydlárová Blaš?áko |
A Case of Multiple Intracranial Major Artery Stenoses With Coexisting PCSK9 p.E32K and RNF213 p.R4810K Variants. Neurology. Genetics 2024 1 9 (5): e200099. Kotaro Noda, Yorito Hattori, Mika Hori, Mariko Harada-Shiba, Masafumi Iha |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 16, 2024
- Content source: